Bolt Biotherapeutics Cash Flow Statement (2020-2026) | BOLT

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-23.59M-23.39M-27.16M-23.68M-22.66M-21.76M-20.00M-16.98M-18.06M-16.26M-17.90M-15.49M-21.20M-15.18M-15.94M-11.06M-8.61M-7.23M-6.72M-7.33M
Depreciation and Depletion (Quarter)
0.20M0.30M0.40M0.40M0.40M0.40M0.50M0.50M0.40M0.50M0.50M1.80M0.40M0.50M0.40M0.40M0.30M0.30M0.30M0.20M
Share-based Compensation (Quarter)
2.02M2.23M2.14M2.92M2.39M2.14M2.12M2.48M2.35M2.33M2.07M2.30M2.83M1.10M1.18M0.71M0.62M0.41M1.04M0.55M
Gains from Sales and Divestitures (Quarter)
0.08M0.06M0.04M
Gains from Investment Securities (Quarter)
-12.18M2.00M10.71M0.07M6.33M0.29M-0.29M0.03M
Non-cash Items (Quarter)
6.08M3.34M0.01M0.35M
Cash from Operations (Quarter)
-3.99M-18.73M-17.79M-24.31M-20.79M-13.45M-17.95M-23.40M-15.11M-16.75M-14.27M-16.75M-16.14M-13.97M-14.43M-13.37M-9.60M-9.73M-7.16M-8.02M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.64M0.76M0.54M-0.47M2.30M0.68M-2.70M0.72M1.25M0.23M0.76M1.03M0.53M0.75M-0.01M0.21M0.17M1.50M0.65M0.67M
Depreciation & Amortization (CF) (Quarter)
0.26M0.30M0.36M0.36M0.41M0.44M0.46M0.47M0.46M0.46M0.47M0.46M0.46M0.44M0.43M0.40M0.35M0.29M0.26M0.20M
Change in Working Capital
Change in Accured Expenses (Quarter)
4.20M3.12M-0.55M-2.39M-0.69M5.57M0.29M-6.61M1.18M0.83M1.19M-3.54M0.92M0.44M-2.70M-2.51M-0.84M-1.88M-0.20M-1.40M
Investing Activities
Capital Expenditures (Quarter)
0.19M0.36M0.43M0.60M-0.51M0.08M-0.17M0.00M0.03M0.17M-0.05M0.04M0.00M0.07M
Sales of Property, Plant and Equipment (Quarter)
0.15M0.96M0.03M
Change in Acquisitions & Divestments (Quarter)
3.80M20.82M51.28M117.53M30.91M50.10M41.98M71.88M67.25M49.13M47.98M33.26M50.23M37.35M25.48M14.58M25.26M19.68M12.91M9.12M
Cash from Investing Activities (Quarter)
-46.60M-16.11M21.03M40.84M-0.87M1.45M16.43M28.99M13.58M12.66M15.81M10.20M18.00M17.14M12.23M14.55M10.79M17.88M1.07M7.92M
Financing Activities
Other financing activities (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
0.44M243.74M0.11M0.25M0.14M0.11M0.03M0.01M0.01M0.01M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
13.41M0.18M0.49M0.11M0.25M0.14M0.11M0.08M0.03M0.01M0.01M0.01M
Change in Cash (Quarter)
-37.18M-34.65M3.73M16.64M-21.40M-12.00M-1.37M5.59M-1.39M-4.09M1.65M-6.55M1.94M3.17M-2.17M1.19M1.21M8.15M-6.08M-0.09M
Free Cash Flow (Quarter)
-4.17M-19.09M-18.22M-24.92M-20.28M-13.54M-17.78M-23.40M-15.14M-16.91M-14.22M-16.75M-16.18M-13.97M-14.43M-13.37M-9.60M-9.80M-7.16M-8.02M
Net Cash Flow (Quarter)
-37.18M-34.65M3.73M16.64M-21.40M-12.00M-1.37M5.59M-1.53M-4.09M1.65M-6.55M1.94M3.17M-2.17M1.19M1.21M8.15M-6.08M-0.09M